NM_000335.5(SCN5A):c.2799_2800del (p.Phe934fs) AND not provided

Germline classification:: Pathogenic (1 submission)
Last evaluated:: May 14, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003542451.2

Allele description [Variation Report for NM_000335.5(SCN5A):c.2799_2800del (p.Phe934fs)]

NM_000335.5(SCN5A):c.2799_2800del (p.Phe934fs)

Genes:

LOC110121269:VISTA enhancer hs2177 [Gene]
SCN5A:sodium voltage-gated channel alpha subunit 5 [Gene - OMIM - HGNC]

Variant type:

Microsatellite

Cytogenetic location:

3p22.2

Genomic location:

Preferred name:

NM_000335.5(SCN5A):c.2799_2800del (p.Phe934fs)

HGVS:

NC_000003.12:g.38581360GA[1]
NG_008934.1:g.73311CT[1]
NG_053884.1:g.3099GA[1]
NM_000335.5:c.2799_2800delMANE SELECT
NM_001099404.2:c.2799_2800del
NM_001099405.2:c.2799_2800del
NM_001160160.2:c.2799_2800del
NM_001160161.2:c.2799_2800del
NM_001354701.2:c.2799_2800del
NM_198056.3:c.2799_2800del
NP_000326.2:p.Phe934Profs
NP_000326.2:p.Phe934fs
NP_001092874.1:p.Phe934Profs
NP_001092874.1:p.Phe934fs
NP_001092875.1:p.Phe934fs
NP_001153632.1:p.Phe934fs
NP_001153633.1:p.Phe934fs
NP_001341630.1:p.Phe934fs
NP_932173.1:p.Phe934Profs
NP_932173.1:p.Phe934fs
LRG_289t1:c.2796_2797TC[1]
LRG_289t2:c.2796_2797TC[1]
LRG_289t3:c.2796_2797TC[1]
LRG_289:g.73311CT[1]
LRG_289p1:p.Phe934Profs
LRG_289p2:p.Phe934Profs
LRG_289p3:p.Phe934Profs
NC_000003.11:g.38622850_38622851del
NC_000003.11:g.38622851GA[1]
NM_000335.4:c.2796_2797TC[1]
NM_001099404.1:c.2796_2797TC[1]
NM_198056.2:c.2796_2797TC[1]
NM_198056.2:c.2799_2800delCT
NR_176299.1:n.3542_3543TC[1]

Protein change:

F934fs

Molecular consequence:

NM_000335.5:c.2799_2800del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001099404.2:c.2799_2800del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001099405.2:c.2799_2800del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001160160.2:c.2799_2800del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001160161.2:c.2799_2800del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001354701.2:c.2799_2800del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_198056.3:c.2799_2800del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003525429	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Pathogenic (May 14, 2022)	germline	clinical testing	PubMed (3) [See all records that cite these PMIDs] 20129283, 22789973, 28492532

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003525429

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Pathogenic
(May 14, 2022)

germline

clinical testing

PubMed (3)
[See all records that cite these PMIDs]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.

Kapplinger JD, Tester DJ, Alders M, Benito B, Berthet M, Brugada J, Brugada P, Fressart V, Guerchicoff A, Harris-Kerr C, Kamakura S, Kyndt F, Koopmann TT, Miyamoto Y, Pfeiffer R, Pollevick GD, Probst V, Zumhagen S, Vatta M, Towbin JA, Shimizu W, Schulze-Bahr E, et al.

Heart Rhythm. 2010 Jan;7(1):33-46. doi: 10.1016/j.hrthm.2009.09.069. Epub 2009 Oct 8.

PubMed [citation]

PMID:: 20129283
PMCID:: PMC2822446

Brugada syndrome 2012.

Berne P, Brugada J.

Circ J. 2012;76(7):1563-71. Epub 2012 Jun 13. Review.

PubMed [citation]

PMID:: 22789973

See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003525429.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Phe934Profs*17) in the SCN5A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SCN5A are known to be pathogenic (PMID: 20129283, 22789973). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SCN5A-related conditions. For these reasons, this variant has been classified as Pathogenic.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 3, 2024

ClinVar

Relating variation to medicine